#immunocore
Latest news and interesting information about immunocore.
Brenetafusp Shows Promise in Melanoma
Immunocore's brenetafusp showed 14.3-month median overall survival in Phase 1/2 melanoma trial, supporting Phase 3 development.
...
→
EN ▾
Starmer refuses to resignCabinet of Ministers issues energy balance decisionRussian army takes control of Yurkovka in Ukraine67 agreements signed in Baku worth $6 billionBus and Changan collide in Hovsan: no injuriesValdas Dambrauskas: Everyone plays football well nowBaku at Center of OIC Anti-Corruption AgendaPeople's Artist Birthday: Agababa BunyadzadeIsDB Head Thanks President for 'Dostlug' OrderFormer Lazio striker loses battle with cancerStarmer refuses to resignCabinet of Ministers issues energy balance decisionRussian army takes control of Yurkovka in Ukraine67 agreements signed in Baku worth $6 billionBus and Changan collide in Hovsan: no injuriesValdas Dambrauskas: Everyone plays football well nowBaku at Center of OIC Anti-Corruption AgendaPeople's Artist Birthday: Agababa BunyadzadeIsDB Head Thanks President for 'Dostlug' OrderFormer Lazio striker loses battle with cancer